You are here

Home » Content

Sigara İçmesine Rağmen Oniki Yılda Progresyon Göstermeyen Pulmoner Langerhans Hücreli Histiyositoz Olgusu

Pulmonary Langerhans Cell Histiocytosis Case that not Shows any Progress although Smoking

Journal Name:

  • Akdeniz Tıp Dergisi

Publication Year:

  • 2017
DOI: 
10.17954/amj.2017.81

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Pulmonary Langerhans Cell Histiocytosis (PLCH) X, which is a subgroup of Langerhans Cell Histiocytosis, is an idiopathic interstitial lung disease in which Langerhans cell infiltration is seen in the lung. There is no certain data on the prevalence of PLHH. In some studies, the estimated prevalence was calculated as 0.27 and 0.07 per 100000 population in males and females respectively. Due to the large number of cases that are smokers, it is considered that the pathogenesis is related to smoking. We are presenting a rare case that has not progressed for 12 years despite smoking.
Bookmark/Search this post with
Abstract (Original Language): 
Pulmoner langerhans hücreli histiositozis (PLHH) X; langerhans hücreli histiyositozisin alt grubu olup akciğerlerde langerhans hücre infiltrasyonunun görüldüğü, nedeni bilinmeyen nadir bir interstisyel akciğer hastalığıdır. PLHH prevalansı ile ilgili kesin bir veri yoktur. Bazı çalışmalarda prevalansı erkekler ve kadınlar için sırasıyla 0,27/100 000 ve 0,07/100 000 olarak tespit edilmiştir. Olguların büyük bir kısmının sigara içicisi olması patogenezinde sigaranın önemli bir yer tuttuğunu düşündürmektedir. Sigara içmesine rağmen 12 yılda progresyon göstermeyen nadir bir olguyu literatür eşliğinde sunuyoruz.
FULL TEXT (PDF): 
PDF icon arastirmax-sigara-icmesine-ragmen-oniki-yilda-progresyon-gostermeyen-pulmoner-langerhans-hucreli-histiyositoz-olgusu.pdf
  • 2
117
121
  • Turkish

REFERENCES

References: 

1. Vassallo R, Ryu JH. Pulmonary Langerhans cell
histiocytosis. Clin Chest Med 2004; 25: 561-71.
2. Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans’
cell histiocytosis. Thorax 2000; 55: 405-16.
3. Gülhan PY, Ekici A, Bulcun E, Ekici MS. Pulmonary
Langerhans Cell Histiocytosis X: An analysis of four
cases. Respir Case Rep 2013;2(3):106-11.
4. Watanabe R, Tatsumi K, Hashimoto S, Kuriyama
T. Clinicoepidemiological features of pulmonary
histiocytosis X. Intern Med 2001; 40: 998-1003.
5. Rao RN, Goodman LR, Tomashefski JF Jr. Smokingrelated
interstitial lung disease. Ann Diagn Pathol 2008;
12: 445-57.
6. Aguayo SM, Kane MA , King TE Jr, Schwarz MI, Grauer
L, Miller YE. Increased levels of bombesin-like peptides
in the lower respiratory tract of asymptomatic cigarette
smokers. J Clin Invest 1989; 84: 1105-13.
7. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic
granuloma of lung. Medicine 1981; 60: 385-96.
8. Baumgartner I, von Hochstetter A, Baumert B, Luetolf
U, Follath F. Langerhans cell histiosytosis in adults. Med
Pediatr Oncol 1997;28:9-14.
9. Sundar KM, Gosselin MV, Chung HL, Cahill BC.
Pulmonary Langerhans cell histiocytosis: Emerging
concepts in pathobiology, radiology, and clinical evolution
of disease. Chest 2003; 123:1673-83.
10. Kulwiec EL, Lynch DA, Aguayo SM, Schwarz MI,
King TE Jr. Imaging of pulmonary histiocytosis X.
Radiographics 1992;12:515-26.
121
Sigara İçmesine Rağmen Oniki Yılda Progresyon Göstermeyen Pulmoner Langerhans Hücreli Histiyositoz Olgusu
Akd Tıp D / Akd Med J / 2017; 2: 117-121
11. Demedts M, Wells AU, Anto JM, Costabel U, Hubbard R,
Cullinan P, Slabbynck H, Rizzato G, Poletti V, Verbeken
EK, Thomeer MJ, Kokkarinen J, Dalphin JC, Taylor AN.
Interstitial lung diseases: An epidemiological overview.
Eur Respir J 2001; 32:2-16.
12. Torre O, Harari S. The diagnosis of cystic lung diseases:
A role for bronchoalveolar lavage and transbronchial
biopsy? Respir Med 2010; 104: 81-5.
13. Tuncay E. Pulmoner Langerhans hücreli histiyositoz.
In: Tabak L, Kumbasar ÖÖ editörler. Toraks Kitapları.
Diffüz Parankimal Akciğer Hastalıkları. Sayı 2013; 17:
283-94.
14. Crausman RS, Jennıngs CA, Tuder RM, Ackerson
LM, Irvın CG, King TE Jr. Pulmonary Histiocytosis X:
Pulmonary function and exercise pathophysiology. Am J
Respir Crit Care Med 1996; 53: 426-35.
15. Vashisht D, Muralidharan CG, Sivasubramanian R,
Gupta MDK, Bharadwaj R, Sengupta P. Histiocytosis.
Medical Journal Armed Forces India 2015;71: 197-200.
16. Hagmeyer L, Randerath W. Smoking-related interstitial
lung disease. Deutsches Ärzteblatt International 2015;
112: 43-50.
17. Ahuja J, Kanne JP, Meyer CA, Pipavath SNJ, Schmidt
RA, Swanson JO, Gdwin JD. Histiocytic disorders of the
chest: Imaging findings. RadioGraphics 2015; 35:357-70.
18. Routy B, Hoang J, Gruber J. Pulmonary Langerhans
Cell Histiocytosis with lytic bone involvement in an adult
smoker: Regression following smoking cessation. Case
Reports in Hematology 2015; 36-41.

Thank you for copying data from http://www.arastirmax.com